| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Tufts University School of Dental Medicine and Veterans Administration Out-Patient Clinic Boston, Massachusetts 02043
Research Laboratory and Department of Medicine (Endocrine Section), Saint Francis Hospital and Medical Center Hartford, Connecticut 06105
the Department of Medicine, University of Connecticut Health Center Farmington, Connecticut, 06032
Address all correspondence and requests for reprints to: Dr. J. M. Hock, Department of General Dentistry, DHS-7, Tufts University School of Dental Medicine, Boston, Massachusetts 02043.
Abstract
Transforming growth factor-β (TGFβ) stimulates the expression of extracellular matrix proteins and may be a local regulator of bone growth. The aims of this research were to localize the effect of TGFjS on bone matrix formation and to determine if this effect was dependent on increased cell replication, using histomorphometry and autoradiography of bone organ cultures. Half-calvariae of 21-day-old fetal rats were cultured with native or recombinant TGFβ1 for 24 h and labeled either with [3H]proline for 0–24 or 24–48 h or with [3H]thymidine for the last 6 h of culture. Bones were fixed in glutaraldehyde, embedded in glycol methacrylate, and processed for autoradiography. Bone matrix formation was assessed as the matrix apposition rate per day and the percentage of [3H]proline-labeled bone surface. Cell replication was evaluated based on the number and percentage of [3H]thymidine labeled cells in the osteoblast cell zone, the osteoprogenitor cell zone, and the pericranial fibroblastic periosteum.
Both native and recombinant TGFβ at 1-30 ng/ml increased bone matrix formation by 25-40% (P < 0.05). At 30 ng/ml, TGFβ had a generalized mitogenic effect as cell replication increased by approximately 2-fold in all cell zones of the pericranial periosteum. TGFβ had specific effects on bone cell differentiation. The number of unlabeled cells lining the bone surface increased, and the number of osteoclasts on bone decreased. Inhibition of cell replication by hydroxyurea only partially blocked the stimulatory effect of TGFβ on bone matrix formation, suggesting that TGFβ may have independent effects on cell replication and differentiated bone cell function. In summary, TGFβ had a generalized mitogenic effect on the pericranial periosteum and specific stimulatory and inhibitory effects on bone cell differentiation and function. (Endocrinology 126: 421–426, 1990)
Footnotes
* This work was supported by NIDR Research Grant DE-07272 and a V.A. Research Associate Career Development Award (to J.M.H.) NIH Grant AR-39201 (to M.C.), and NIAMSD Grant AR-21707 (to E.C.). The research was carried out at the V.A. Medical Center (Newington, CT) and Saint Francis Hospital (Hartford, CT). These studies were presented in part at the Second Workshop on Cells and Cytokines in Bone and Cartilage, Davos, Switzerland, April 9-12, 1988.
Received July 27, 1989.
This article has been cited by other articles:
![]() |
K. Janssens, P. ten Dijke, S. Janssens, and W. Van Hul Transforming Growth Factor-{beta}1 to the Bone Endocr. Rev., October 1, 2005; 26(6): 743 - 774. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lu, M. J. Yaszemski, and A. G. Mikos TGF-{beta}1 Release from Biodegradable Polymer Microparticles: Its Effects on Marrow Stromal Osteoblast Function J. Bone Joint Surg. Am., April 1, 2001; 83(90010): S82 - 92. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lu, M. J. Yaszemski, and A. G. Mikos TGF-{beta}1 Release from Biodegradable Polymer Microparticles: Its Effects on Marrow Stromal Osteoblast Function J. Bone Joint Surg. Am., April 1, 2001; 83(1_suppl_2): S82 - S92. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kaneda, T. Nojima, M. Nakagawa, A. Ogasawara, H. Kaneko, T. Sato, H. Mano, M. Kumegawa, and Y. Hakeda Endogenous Production of TGF-{beta} Is Essential for Osteoclastogenesis Induced by a Combination of Receptor Activator of NF-{kappa}B Ligand and Macrophage-Colony- Stimulating Factor J. Immunol., October 15, 2000; 165(8): 4254 - 4263. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Gal, T. Munoz-Antonia, C. A. Muro-Cacho, and D. W. Klotch Radiation Effects on Osteoblasts In Vitro: A Potential Role in Osteoradionecrosis Arch Otolaryngol Head Neck Surg, September 1, 2000; 126(9): 1124 - 1128. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Suzawa, Y. Takeuchi, S. Fukumoto, S. Kato, N. Ueno, K. Miyazono, T. Matsumoto, and T. Fujita Extracellular Matrix-Associated Bone Morphogenetic Proteins Are Essential for Differentiation of Murine Osteoblastic Cells in Vitro Endocrinology, May 1, 1999; 140(5): 2125 - 2133. [Abstract] [Full Text] |
||||
![]() |
E. Gazzerro, S. Rydziel, and E. Canalis Skeletal Bone Morphogenetic Proteins Suppress the Expression of Collagenase-3 by Rat Osteoblasts Endocrinology, February 1, 1999; 140(2): 562 - 567. [Abstract] [Full Text] |
||||
![]() |
M. Dodig, MarkS. Kronenberg, A. Bedalov, BarbaraE. Kream, G. Gronowicz, StephenH. Clark, K. Mack, Y.-H. Liu, R. Maxon, Z. Pan, et al. Identification of a TAAT-containing Motif Required for High Level Expression of the COL1A1 Promoter in Differentiated Osteoblasts of Transgenic Mice J. Biol. Chem., July 5, 1996; 271(27): 16422 - 16429. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Takeuchi, K. Nakayama, and T. Matsumoto Differentiation and Cell Surface Expression of Transforming Growth Factor-beta Receptors Are Regulated by Interaction with Matrix Collagen in Murine Osteoblastic Cells J. Biol. Chem., February 16, 1996; 271(7): 3938 - 3944. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Critchlow, Y. Bland, and D. Ashhurst The effects of age on the response of rabbit periosteal osteoprogenitor cells to exogenous transforming growth factor-beta 2 J. Cell Sci., January 2, 1994; 107(2): 499 - 516. [Abstract] [PDF] |
||||
![]() |
T. Saito, A. Kinoshita, K.-i. Yoshiura, Y. Makita, K. Wakui, K. Honke, N. Niikawa, and N. Taniguchi Domain-specific Mutations of a Transforming Growth Factor (TGF)-beta 1 Latency-associated Peptide Cause Camurati-Engelmann Disease Because of the Formation of a Constitutively Active Form of TGF-beta 1 J. Biol. Chem., April 6, 2001; 276(15): 11469 - 11472. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |